SEC Form 4 · accession 0001179110-18-004253

Care.com Inc · CRCM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Michael Echenberg

Officer — Chief Financial Officer

Period of report

Mar 9, 2018

Accepted (ET)

Mar 13, 2018 · 8:23 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001412270

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock, $0.001 par value^F1	Mar 9, 2018	M	7,825	—	A	26,972	D
Common Stock, $0.001 par value^F1	Mar 9, 2018	M	2,332	—	A	29,304	D
Common Stock, $0.001 par value^F1	Mar 9, 2018	M	544	—	A	29,848	D
Common Stock, $0.001 par value^F1	Mar 9, 2018	M	1,284	—	A	31,132	D
Common Stock, $0.001 par value	Mar 12, 2018	M	1,000	$6.70	A	32,132	D
Common Stock, $0.001 par value^F3	Mar 12, 2018	S	1,500	$18.798	D	30,632	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted Stock Units^F1,F4	—	Mar 9, 2018	M	7,825	D	—	—	Common Stock	7,825	39,125	D
Restricted Stock Units^F1,F5	—	Mar 9, 2018	M	2,332	D	—	—	Common Stock	2,332	18,655	D
Restricted Stock Units^F1,F6	—	Mar 9, 2018	M	544	D	—	—	Common Stock	544	4,354	D
Restricted Stock Units^F1,F7	—	Mar 9, 2018	M	1,284	D	—	—	Common Stock	1,284	15,413	D
Restricted Stock Units^F1,F8	—	Mar 9, 2018	A	21,008	A	—	—	Common Stock	21,008	21,008	D
Restricted Stock Units^F1,F9	—	Mar 9, 2018	A	36,956	A	—	Mar 8, 2023	Common Stock	36,956	36,956	D
Restricted Stock Units^F1,F10	—	Mar 9, 2018	A	39,666	A	—	Mar 8, 2023	Common Stock	39,666	39,666	D
Stock Option (Right to Buy)^F11	$6.70	Mar 12, 2018	M	1,000	D	—	Mar 10, 2026	Common Stock	1,000	77,780	D

Explanation of responses

F1Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F10The restricted stock units vest upon the Issuer's common stock achieving a 120-day volume-weighted average price of $30.
F11The option will vest as to 6.25% of the original number of securities acquired at the end of each successive three month period from March 9, 2016 until March 9, 2020.
F2The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 13, 2017.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.70 to $18.97, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.
F4The restricted stock units will vest as to 25% of the original number of restricted stock units on June 9, 2016 and as to an additional 6.25% of the original number of restricted stock units at the end of each successive three month period from June 9, 2016 until June 9, 2019. The restricted stock units have no expiration date.
F5The restricted stock units will vest as to 6.25% of the original restricted stock units at the end of each successive three month period from March 9, 2016 until March 9, 2020. The restricted stock units have no expiration date.
F6The restricted stock units will vest as to 25% of the original grant on March 9, 2017. The balance of the grant will vest in twelve equal quarterly installments beginning on June 9, 2017. The restricted stock units have no expiration date.
F7The restricted stock units will vest in sixteen equal installments beginning on June 9, 2017. The restricted stock units have no expiration date.
F8The restricted stock units will vest in sixteen equal quarterly installments beginning on June 9, 2018. The restricted stock units have no expiration date.
F9The restricted stock units vest upon the Issuer's common stock achieving a 120-day volume-weighted average price of $23.